These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38675723)

  • 1. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
    Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
    Yuan S; Xu Y; Yi T; Wang H
    J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT).
    Maleki N; Yavari N; Ebrahimi M; Faisal Faiz A; Khosh Ravesh R; Sharbati A; Panji M; Lorian K; Gravand A; Abbasi M; Abazari O; Shafiee Mehr M; Eskandari Y
    Gene; 2022 May; 823():146275. PubMed ID: 35189245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
    Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
    Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Emodin in the Treatment of Bladder Cancer Based on Network Pharmacology and Experimental Verification.
    Liu F; Li J; Zhou B; Shen Y; Tang J; Han J; Chen C; Shao K; Chen H; Yuan L
    Comb Chem High Throughput Screen; 2024; 27(11):1661-1675. PubMed ID: 38504574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating UHPLC-Q-TOF-MS/MS, network pharmacology, bioinformatics and experimental validation to uncover the anti-cancer mechanisms of TiaoPi AnChang decoction in colorectal cancer.
    Guo Y; Yuan C; Huang T; Cheng Z
    J Ethnopharmacol; 2024 Nov; 334():118576. PubMed ID: 39002822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics.
    Hu B; Wang C; Wu Y; Han C; Liu J; Chen R; Wang T
    J Ethnopharmacol; 2024 Aug; 330():118228. PubMed ID: 38643863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
    Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
    Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect and mechanism of silibinin on the inhibition of ALK positive NSCLC cells by sensitizing crizotinib].
    Lin CC; Lu CH; Pan YH; Jiao L; Chen HY; Li L; He Y
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):650-656. PubMed ID: 28926892
    [No Abstract]   [Full Text] [Related]  

  • 10. Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration.
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Aug; 128():110366. PubMed ID: 32526459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disclosing targets and pharmacological mechanisms of total bioflavonoids extracted from Selaginella doederleinii against non-small cell lung cancer by combination of network pharmacology and proteomics.
    Xu D; Wang X; Huang D; Chen B; Lin X; Liu A; Huang J
    J Ethnopharmacol; 2022 Mar; 286():114836. PubMed ID: 34793885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
    Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells.
    Rugamba A; Kang DY; Sp N; Jo ES; Lee JM; Bae SW; Jang KJ
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
    Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
    Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
    Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
    Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
    Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
    J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin inhibits epithelial‑mesenchymal transition of renal cell carcinoma through autophagy‑dependent Wnt/β‑catenin signaling.
    Fan Y; Hou T; Dan W; Liu T; Luan J; Liu B; Li L; Zeng J
    Int J Mol Med; 2020 May; 45(5):1341-1350. PubMed ID: 32323735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
    ShuoWang ; Song Z; Gong X; Ou C; Zhang W; Wang J; Yao C; Qin S; Yan B; Li Q; Wei K; Hou X; Zhou X; Miao J
    J Ethnopharmacol; 2021 May; 271():113879. PubMed ID: 33524509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.